Cargando…

The potential for enhanced tumour localisation by poly(ethylene glycol) modification of anti-CEA antibody.

Attachment of poly(ethylene glycol) (PEG) to proteins can greatly alter their pharmacological properties, including extending the plasma half-life and reducing immunogenicity, both of which are potentially beneficial to tumour targeting. IgG, F(ab')2 and Fab' fragments of the anti-CEA anti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pedley, R. B., Boden, J. A., Boden, R., Begent, R. H., Turner, A., Haines, A. M., King, D. J.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1994
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033704/ https://www.ncbi.nlm.nih.gov/pubmed/7981064

Ejemplares similares

Enhanced tumour specificity of an anti-carcinoembrionic antigen Fab' fragment by poly(ethylene glycol) (PEG) modification.
por: Delgado, C., et al.
Publicado: (1996)

Polyethylene glycol modification of a galactosylated streptavidin clearing agent: effects on immunogenicity and clearance of a biotinylated anti-tumour antibody.
por: Marshall, D., et al.
Publicado: (1996)

Prolonged localisation of a monoclonal antibody against CEA in a human colon tumour xenograft.
por: Harwood, P. J., et al.
Publicado: (1985)

The effect of serum CEA on the distribution and clearance of anti-CEA antibody in a pancreatic tumour xenograft model.
por: Pedley, R. B., et al.
Publicado: (1989)

Comparative radioimmunotherapy using intact or F(ab')2 fragments of 131I anti-CEA antibody in a colonic xenograft model.
por: Pedley, R. B., et al.
Publicado: (1993)

Dose-dependent localisation and potential for therapy of F(ab')2 fragments against CEA studied in a human tumour xenograft model.
por: Rogers, G. T., et al.
Publicado: (1986)

Localisation of monoclonal antibodies reacting with different epitopes on carcinoembryonic antigen (CEA)--implications for targeted therapy.
por: Boxer, G. M., et al.
Publicado: (1994)

Galactosylated streptavidin for improved clearance of biotinylated intact and F(ab')2 fragments of an anti-tumour antibody.
por: Marshall, D., et al.
Publicado: (1995)

Clearance of yttrium-90-labelled anti-tumour antibodies with antibodies raised against the 12N4 DOTA macrocycle.
por: Casey, J. L., et al.
Publicado: (1998)

Clearance of circulating radio-antibodies using streptavidin or second antibodies in a xenograft model.
por: Marshall, D., et al.
Publicado: (1994)

Fractionated (131)I anti-CEA radioimmunotherapy: effects on xenograft tumour growth and haematological toxicity in mice
por: Violet, J A, et al.
Publicado: (2008)

Comparative biodistributions of indium-111-labelled macrocycle chimeric B72.3 antibody conjugates in tumour-bearing mice.
por: Turner, A., et al.
Publicado: (1994)

Inactivation and clearance of an anti-CEA carboxypeptidase G2 conjugate in blood after localisation in a xenograft model.
por: Sharma, S. K., et al.
Publicado: (1990)

Factors influencing variability of localisation of antibodies to carcinoembryonic antigen (CEA) in patients with colorectal carcinoma--implications for radioimmunotherapy.
por: Boxer, G. M., et al.
Publicado: (1992)

Formulation of polylactide-co-glycolic acid nanospheres for encapsulation and sustained release of poly(ethylene imine)-poly(ethylene glycol) copolymers complexed to oligonucleotides
por: Sirsi, Shashank R, et al.
Publicado: (2009)

Preparation and Characterization of Poly(Lactic Acid)/Poly (ethylene glycol)-Poly(propyl glycol)-Poly(ethylene glycol) Blended Nanofiber Membranes for Fog Collection
por: Aijaz, Muhammad Omer, et al.
Publicado: (2022)

Modification of Poly(Ethylene 2,5-Furandicarboxylate) with Poly(Ethylene glycol) for Biodegradable Copolyesters with Good Mechanical Properties and Spinnability
por: Ji, Peng, et al.
Publicado: (2019)

The potential of carboxypeptidase G2: antibody conjugates as anti-tumour agents. II. In vivo localising and clearance properties in a choriocarcinoma model.
por: Melton, R. G., et al.
Publicado: (1990)

Preparation, characterisation and tumour targeting of cross-linked divalent and trivalent anti-tumour Fab' fragments.
por: Casey, J. L., et al.
Publicado: (1996)

Preliminary observations on the microdistribution of labelled antibodies in human colonic adenocarcinoma xenografts: relevance to microdosimetry.
por: Pedley, R. B., et al.
Publicado: (1990)

Relationships between Poly(ethylene glycol) Modifications on RNA–Spherical Nucleic Acid Conjugates and Cellular Uptake and Circulation Time
por: Chinen, Alyssa B., et al.
Publicado: (2016)

Non-Isothermal Crystallization Kinetics of Poly(ethylene glycol) and Poly(ethylene glycol)-B-Poly(ε-caprolactone) by Flash DSC Analysis
por: Li, Xiaodong, et al.
Publicado: (2021)

Influence of Poly(Ethylene Glycol) End Groups on Poly(Ethylene Glycol)-Albumin System Properties as a Potential Degradable Tissue Scaffold
por: Overby, Robyn J., et al.
Publicado: (2018)

Isothermal Crystallization Kinetics of Poly(ethylene oxide)/Poly(ethylene glycol)-g-silica Nanocomposites
por: Wen, Xiangning, et al.
Publicado: (2021)

Clinical Relevance of Pre-Existing and Treatment-Induced Anti-Poly(Ethylene Glycol) Antibodies
por: Freire Haddad, Helena, et al.
Publicado: (2021)

Poly(Ethylene Glycol)–Polylactide Micelles for Cancer Therapy
por: Wang, Jixue, et al.
Publicado: (2018)

Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab́ fragments
por: Casey, J L, et al.
Publicado: (1999)

Water Swelling Behavior of Poly(ethylene glycol)-Based Polyurethane Networks
por: Albers, Peter T. M., et al.
Publicado: (2020)

Biodegradable nanoparticles of methoxy poly(ethylene glycol)-b-poly( d, l-lactide)/methoxy poly(ethylene glycol)- b-poly(ϵ-caprolactone) blends for drug delivery
por: Baimark, Yodthong, et al.
Publicado: (2012)

Hydrophilization of Poly(Caprolactone) Copolymers through Introduction of Oligo(Ethylene Glycol) Moieties
por: Wurth, Jonathan J., et al.
Publicado: (2014)

Modification of Alkali Lignin with Poly(Ethylene Glycol) Diglycidyl Ether to Be Used as a Thickener in Bio-Lubricant Formulations
por: Cortés-Triviño, Esperanza, et al.
Publicado: (2018)

Development of PLA/Lignin Bio-Composites Compatibilized by Ethylene Glycol Diglycidyl Ether and Poly (ethylene glycol) Diglycidyl Ether
por: Shakoor Shar, Abdul, et al.
Publicado: (2023)

Non-Isothermal Crystallization Kinetics of Poly(Ethylene Glycol)–Poly(l-Lactide) Diblock Copolymer and Poly(Ethylene Glycol) Homopolymer via Fast-Scan Chip-Calorimeter
por: Chen, Dejia, et al.
Publicado: (2021)

Localisation of gastrointestinal cancer with a 131 I labelled monoclonal antibody to CEA.
por: Allum, W. H., et al.
Publicado: (1986)

The site of binding of anti-CEA antibodies to tumour CEA in vivo: an immunocytochemical and autoradiographic approach.
por: Moshakis, V., et al.
Publicado: (1982)

Altered biodistribution of an antibody--enzyme conjugate modified with polyethylene glycol.
por: Eno-Amooquaye, E. A., et al.
Publicado: (1996)

Preparation and Characterization of Electrospun Poly(lactic acid)/Poly(ethylene glycol)–b–poly(propylene glycol)–b–poly(ethylene glycol)/Silicon Dioxide Nanofibrous Adsorbents for Selective Copper (II) Ions Removal from Wastewater
por: Aijaz, Muhammad Omer, et al.
Publicado: (2023)

Interaction of Hyaluronan Binding Peptides with Glycosaminoglycans in Poly(ethylene glycol) Hydrogels
por: Roberts, Justine J., et al.
Publicado: (2014)

Localisation and toxicity study of a vindesine-anti-CEA conjugate in patients with advanced cancer.
por: Ford, C. H., et al.
Publicado: (1983)

Using anti-poly(ethylene glycol) bioparticles for the quantitation of PEGylated nanoparticles
por: Hsieh, Yuan-Chin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gov6t218alm1j7lmuaccca7cu0